Display Shows:

My Language:

Insidermedicine Daily News (Video)

Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...

Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.

Show all Visit Show Website http://www.insidermedicine.ca

Recently Aired


  • HD

    Post-stroke quality of life may be worse in women than men

    (July 25, 2012 - Insidermedicine) From Sweden - Women have ...

    (July 25, 2012 - Insidermedicine) From Sweden - Women have worse quality of life following a stroke than men, according to a report published in the Journal of Clinical Nursing. Researchers followed nearly 500 stroke and ministroke patients, finding that women were significantly more harmed in nearly all quality of life categories, including, emotion, sleep, energy, pain and mobility.

    Jul 25, 2012 Read more
  • HD

    New chemical may potentially treat inherited blindness

    (July 25, 2012 - Insidermedicine) From California - Scientists have ...

    (July 25, 2012 - Insidermedicine) From California - Scientists have discovered a chemical that restores vision in blind mice, according to a report published in Neuron. Researchers genetically engineered mice to lose their vision months after birth, injecting the rodents with a  'photoswitch' chemical known as AAQ. They found that the chemical restored partial vision to the rodents--offering hope for the treatment of retinitis pigmentosa, the most common form of inherited blindness

    Jul 25, 2012 Read more
  • HD

    Scientists restore vision in blind mice; Sickle cell trait and sudden cardiac death in black athletes; Women may suffer more following a stroke than men

    (July 25, 2012 - Insidermedicine) From California - Scientists have ...

    (July 25, 2012 - Insidermedicine) From California - Scientists have discovered a chemical that restores vision in blind mice, according to a report published in Neuron. Researchers genetically engineered mice to lose their vision months after birth, injecting the rodents with a  'photoswitch' chemical known as AAQ. They found that the chemical restored partial vision to the rodents--offering hope for the treatment of retinitis pigmentosa, the most common form of inherited blindness. From Minneapolis - Sickle cell trait has once again been linked to sudden cardiac death in black athletes, according to research published in the American Journal of Cardiology. Analysis of the US Sudden Death in Athletes Registry revealed that a significant amount of sudden cardiac deaths among athletes occurred in young black males who had the sickle cell trait. From Sweden - Women have worse quality of life following a stroke than men, according to a report published in the Journal of Clinical Nursing. Researchers followed nearly 500 stroke and ministroke patients, finding that women were significantly more harmed in nearly all quality of life categories, including, emotion, sleep, energy, pain and mobility.

    Jul 25, 2012 Read more
  • HD

    Treating undiagnosed heart problems in very elderly can extend their life

    (July 24, 2012 - Insidermedicine) From Newcastle - A quarter ...

    (July 24, 2012 - Insidermedicine) From Newcastle - A quarter of very elderly people have treatable heart problems that are going undiagnosed, according to a report published in Heart. Studying nearly 400 people between 87-89 years old, researchers found that 26% had a previously undiagnosed heart problem that could be easily treated with medications that would likely prolong their life

    Jul 24, 2012 Read more
  • HD

    Scientists develop new class of drugs that may prevent Alzheimer's, multiple sclerosis and traumatic brain injury

    (July 24, 2012 - Insidermedicine) From Chicago - A new ...

    (July 24, 2012 - Insidermedicine) From Chicago - A new class of drug may potentially treat Alzheimer's disease, multiple sclerosis and traumatic brain injury, according to a report published in the Journal of Neuroscience. Researchers studied mice genetically engineered to develop Alzheimer's disease or multiple sclerosis, and found that giving the rodents the new class of drugs prevented onset of both conditions, and also prevented long term complications following a traumatic brain injury.

    Jul 24, 2012 Read more
  • HD

    Tanning beds linked to over 3,000 melanoma cases every year in Europe

    (July 24, 2012 - Insidermedicine)  From France - Tanning beds ...

    (July 24, 2012 - Insidermedicine)  From France - Tanning beds lead to over 3,000 cases of melanoma in Europe each year, according to a report published in the BMJ. Results of a meta-analysis examining 27 studies found that over 3,000 of nearly 64,000 melanoma cases in Europe every year are caused by tanning bed use. Risk of skin cancer was increased by 87% if tanning bed use occurred before 35 years of age

    Jul 24, 2012 Read more
  • HD

    Indoor tanning linked to melanoma; New drugs may treat multiple neurological conditions including Alzheimer's; Undiagnosed heart problems common in the very elderly

    (July 24, 2012 - Insidermedicine) From France - Tanning beds ...

    (July 24, 2012 - Insidermedicine) From France - Tanning beds lead to over 3,000 cases of melanoma in Europe each year, according to a report published in the BMJ. Results of a meta-analysis examining 27 studies found that over 3,000 of nearly 64,000 melanoma cases in Europe every year are caused by tanning bed use. Risk of skin cancer was increased by 87% if tanning bed use occurred before 35 years of age. From Chicago - A new class of drug may potentially treat Alzheimer's disease, multiple sclerosis and traumatic brain injury, according to a report published in the Journal of Neuroscience. Researchers studied mice genetically engineered to develop Alzheimer's disease or multiple sclerosis, and found that giving the rodents the new class of drugs prevented onset of both conditions, and also prevented long term complications following a traumatic brain injury. From Newcastle - A quarter of very elderly people have treatable heart problems that are going undiagnosed, according to a report published in Heart. Studying nearly 400 people between 87-89 years old, researchers found that 26% had a previously undiagnosed heart problem that could be easily treated with medications that would likely prolong their life.

    Jul 24, 2012 Read more
  • HD

    Vitamins C, E, and selenium in the diet significantly lower risk of pancreatic cancer

    (July 23, 2012 - Insidermedicine) From the UK - A ...

    (July 23, 2012 - Insidermedicine) From the UK - A new report published in Gut finds that high dietary intake of antioxidants may lower risk of pancreatic cancer. Researchers examined the food diaries of over 23,000 adults taking part in a 10 year study. They found that those with the highest dietary intake of vitamins C, E and selenium had a 67% reduced risk of developing pancreatic cancer.

    Jul 23, 2012 Read more
  • HD

    Two thirds of severely obese children have heart disease risk factors

    (July 23, 2012 - Insidermedicine) From the Netherlands - Two ...

    (July 23, 2012 - Insidermedicine) From the Netherlands - Two thirds of severely obese children already have risk factors for heart disease, according to a report published in the Archives of Disease in Childhood. Researchers reviewed pediatric data on all new severely obese children in the Netherlands. Results showed that two out of three children had at least one heart disease risk factor, 56% had high blood pressure, 54% had high levels of bad cholesterol, and 14% had high fasting blood glucose.

    Jul 23, 2012 Read more
  • HD

    Over half of very obese children have high blood pressure, bad cholesterol; Novel drug combo for TB; Antioxidants may lower risk of pancreatic cancer

    (July 23, 2012 - Insidermedicine) From the Netherlands - Two ...

    (July 23, 2012 - Insidermedicine) From the Netherlands - Two thirds of severely obese children already have risk factors for heart disease, according to a report published in the Archives of Disease in Childhood. Researchers reviewed pediatric data on all new severely obese children in the Netherlands. Results showed that two out of three children had at least one heart disease risk factor, 56% had high blood pressure, 54% had high levels of bad cholesterol, 14% had high fasting blood glucose. From South Africa - A novel drug combination may greatly improve treatment of tuberculosis, according to a report published in the Lancet. Researchers combined a new tuberculosis drug, PA-284, with moxifloxacin in a study of 85 TB patients. Within two weeks, the drug combo was found to have killed over 99% of TB bacteria in the study participants. From the UK - A new report published in Gut finds that high dietary intake of antioxidants may lower risk of pancreatic cancer. Researchers examined the food diaries of over 23,000 adults taking part in a 10 year study. They found that those with the highest dietary intake of vitamins C, E and selenium had a 67% reduced risk of developing pancreatic cancer.

    Jul 23, 2012 Read more
Loading...